{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:12:33Z","timestamp":1793146353919,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671371"],"award-info":[{"award-number":["81671371"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81271523"],"award-info":[{"award-number":["81271523"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Municipal Science and Technology Commission","award":["18XD1403400"],"award-info":[{"award-number":["18XD1403400"]}]},{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic Research Leader","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.canlet.2019.05.043","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T15:53:50Z","timestamp":1559836430000},"page":"135-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["DEPTOR inhibits cell proliferation and confers sensitivity to dopamine agonist in pituitary adenoma"],"prefix":"10.1016","volume":"459","author":[{"given":"Hong","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu Fen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Ting","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Zhi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Bing","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Xu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6558-791X","authenticated-orcid":false,"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1611-8228","authenticated-orcid":false,"given":"Zhe Bao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.canlet.2019.05.043_bib1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/ng.3322","article-title":"Common variants at 10p12.31, 10q21.1 and 13q12.13 are associated with sporadic pituitary adenoma","volume":"47","author":"Ye","year":"2015","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.canlet.2019.05.043_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nrendo.2014.181","article-title":"Genetic mutations in sporadic pituitary adenomas--what to screen for?","volume":"11","author":"Lecoq","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"issue":"19","key":"10.1016\/j.canlet.2019.05.043_bib3","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJMc1000094","article-title":"Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease","volume":"362","author":"Feelders","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.canlet.2019.05.043_bib4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1507\/endocrj.EJ12-0272","article-title":"Efficacy of combined octreotide and cabergoline treatment in patients with acromegaly: a retrospective clinical study and review of the literature","volume":"60","author":"Suda","year":"2013","journal-title":"Endocr. J."},{"issue":"5","key":"10.1016\/j.canlet.2019.05.043_bib5","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/cen.12684","article-title":"Dopamine receptor subtype 2 expression profile in nonfunctioning pituitary adenomas and in vivo response to cabergoline therapy","volume":"82","author":"Vieira Neto","year":"2015","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"10.1016\/j.canlet.2019.05.043_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.canlet.2016.08.005","article-title":"Dopamine receptor type 2 (DRD2) inhibits migration and invasion of human tumorous pituitary cells through ROCK-mediated cofilin inactivation","volume":"381","author":"Peverelli","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.05.043_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/B978-0-444-59602-4.00013-7","article-title":"Hyperprolactinemia and prolactinoma","volume":"124","author":"Romijn","year":"2014","journal-title":"Handb. Clin. Neurol."},{"issue":"5","key":"10.1016\/j.canlet.2019.05.043_bib8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1158\/1541-7786.MCR-15-0480","article-title":"Reciprocal negative regulation between EGFR and DEPTOR plays an important role in the progression of lung adenocarcinoma","volume":"14","author":"Zhou","year":"2016","journal-title":"Mol. Cancer Res."},{"issue":"2","key":"10.1016\/j.canlet.2019.05.043_bib9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"169","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.canlet.2019.05.043_bib10","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/onc.2016.264","article-title":"mTOR promotes pituitary tumor development through activation of PTTG1","volume":"36","author":"Chen","year":"2017","journal-title":"Oncogene"},{"issue":"14","key":"10.1016\/j.canlet.2019.05.043_bib11","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1158\/1078-0432.CCR-15-0288","article-title":"Targeting PI3K\/mTOR signaling displays potent antitumor efficacy against nonfunctioning pituitary adenomas","volume":"21","author":"Lee","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2019.05.043_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11060-015-1895-x","article-title":"Specific inhibition of mTOR pathway induces anti-proliferative effect and decreases the hormone secretion in cultured pituitary adenoma cells","volume":"125","author":"Xie","year":"2015","journal-title":"J. Neuro Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2019.05.043_bib13","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1158\/0008-5472.CAN-09-2951","article-title":"The somatostatin analogue octreotide confers sensitivity to rapamycin treatment on pituitary tumor cells","volume":"70","author":"Cerovac","year":"2010","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.canlet.2019.05.043_bib14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2009.03.046","article-title":"DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival","volume":"137","author":"Peterson","year":"2009","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.canlet.2019.05.043_bib15","doi-asserted-by":"crossref","first-page":"12811","DOI":"10.18632\/oncotarget.2659","article-title":"DEPTOR has growth suppression activity against pancreatic cancer cells","volume":"5","author":"Li","year":"2014","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.canlet.2019.05.043_bib16","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.bbrc.2015.03.148","article-title":"DEPTOR-related mTOR suppression is involved in metformin's anti-cancer action in human liver cancer cells","volume":"460","author":"Obara","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.canlet.2019.05.043_bib17","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.7314\/APJCP.2014.15.11.4589","article-title":"DEPTOR expression negatively correlates with mTORC1 activity and tumor progression in colorectal cancer","volume":"15","author":"Lai","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"3","key":"10.1016\/j.canlet.2019.05.043_bib18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s12020-015-0824-2","article-title":"Dopamine agonist resistance-related endocan promotes angiogenesis and cells viability of prolactinomas","volume":"52","author":"Cai","year":"2016","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.canlet.2019.05.043_bib19","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3171\/2010.11.JNS101369","article-title":"Dopamine agonist-resistant prolactinomas","volume":"114","author":"Oh","year":"2011","journal-title":"J. Neurosurg."},{"issue":"2","key":"10.1016\/j.canlet.2019.05.043_bib20","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s12020-018-1702-5","article-title":"Cabergoline for the treatment of bromocriptine-resistant invasive giant prolactinomas","volume":"62","author":"Huang","year":"2018","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.canlet.2019.05.043_bib21","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1002\/hep.24291","article-title":"RN181 suppresses hepatocellular carcinoma growth by inhibition of the ERK\/MAPK pathway","volume":"53","author":"Wang","year":"2011","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.canlet.2019.05.043_bib22","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/onc.2016.275","article-title":"DEPTOR is a direct NOTCH1 target that promotes cell proliferation and survival in T-cell leukemia","volume":"36","author":"Hu","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.canlet.2019.05.043_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13046-016-0484-y","article-title":"Deptor: not only a mTOR inhibitor","volume":"36","author":"Catena","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.canlet.2019.05.043_bib24","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1152\/physrev.00064.2017","article-title":"DEPTOR at the nexus of cancer, metabolism, and immunity","volume":"98","author":"Caron","year":"2018","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.canlet.2019.05.043_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1022375429083","article-title":"Medical management of prolactin-secreting pituitary adenomas","volume":"5","author":"Molitch","year":"2002","journal-title":"Pituitary"},{"issue":"36","key":"10.1016\/j.canlet.2019.05.043_bib26","doi-asserted-by":"crossref","first-page":"39329","DOI":"10.18632\/oncotarget.5744","article-title":"Suppression of mTOR pathway and induction of autophagy-dependent cell death by cabergoline","volume":"6","author":"Lin","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.canlet.2019.05.043_bib27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.molcel.2011.09.005","article-title":"mTOR generates an auto-amplification loop by triggering the betaTrCP- and CK1alpha-dependent degradation of DEPTOR","volume":"44","author":"Duan","year":"2011","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.canlet.2019.05.043_bib28","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.molcel.2011.08.030","article-title":"mTOR drives its own activation via SCF(betaTrCP)-dependent degradation of the mTOR inhibitor DEPTOR","volume":"44","author":"Gao","year":"2011","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.canlet.2019.05.043_bib29","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.molcel.2011.08.029","article-title":"DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(betaTrCP) E3 ubiquitin ligase and regulates survival and autophagy","volume":"44","author":"Zhao","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2019.05.043_bib30","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1038\/emm.2014.127","article-title":"beta-TrCP1 degradation is a novel action mechanism of PI3K\/mTOR inhibitors in triple-negative breast cancer cells","volume":"47","author":"Yi","year":"2015","journal-title":"Exp. Mol. Med."},{"issue":"8","key":"10.1016\/j.canlet.2019.05.043_bib31","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1080\/15548627.2017.1328347","article-title":"Activation of DRD5 (dopamine receptor D5) inhibits tumor growth by autophagic cell death","volume":"13","author":"Leng","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2019.05.043_bib32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.wneu.2017.01.052","article-title":"Bromocriptine induces autophagy-dependent cell death in pituitary adenomas","volume":"100","author":"Geng","year":"2017","journal-title":"World Neurosurg."},{"issue":"11","key":"10.1016\/j.canlet.2019.05.043_bib33","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.tcb.2012.08.008","article-title":"The pantheon of the fallen: why are there so many forms of cell death?","volume":"22","author":"Green","year":"2012","journal-title":"Trends Cell Biol."},{"issue":"5","key":"10.1016\/j.canlet.2019.05.043_bib34","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1593\/neo.12542","article-title":"An evolving role for DEPTOR in tumor development and progression","volume":"14","author":"Wang","year":"2012","journal-title":"Neoplasia"},{"issue":"10","key":"10.1016\/j.canlet.2019.05.043_bib35","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3109\/10428194.2011.580478","article-title":"The mammalian target of rapamycin pathway as a therapeutic target in multiple myeloma","volume":"52","author":"Gera","year":"2011","journal-title":"Leuk. Lymphoma"},{"issue":"11\u201312","key":"10.1016\/j.canlet.2019.05.043_bib36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.18632\/genesandcancer.44","article-title":"DEPTOR is linked to a TORC1-p21 survival proliferation pathway in multiple myeloma cells","volume":"5","author":"Yang","year":"2014","journal-title":"Genes Canc."},{"issue":"17","key":"10.1016\/j.canlet.2019.05.043_bib37","doi-asserted-by":"crossref","first-page":"24154","DOI":"10.18632\/oncotarget.8131","article-title":"DEPTOR promotes survival of cervical squamous cell carcinoma cells and its silencing induces apoptosis through downregulating PI3K\/AKT and by up-regulating p38 MAP kinase","volume":"7","author":"Srinivas","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.canlet.2019.05.043_bib38","first-page":"817","article-title":"Overexpression of DEP domain containing mTOR-interacting protein correlates with poor prognosis in differentiated thyroid carcinoma","volume":"4","author":"Pei","year":"2011","journal-title":"Mol. Med. Rep."},{"issue":"43","key":"10.1016\/j.canlet.2019.05.043_bib39","doi-asserted-by":"crossref","first-page":"70546","DOI":"10.18632\/oncotarget.12060","article-title":"Deptor transcriptionally regulates endoplasmic reticulum homeostasis in multiple myeloma cells","volume":"7","author":"Catena","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.canlet.2019.05.043_bib40","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s11102-009-0168-0","article-title":"Secondary resistance to cabergoline therapy in a macroprolactinoma: a case report and literature review","volume":"14","author":"Behan","year":"2011","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.canlet.2019.05.043_bib41","first-page":"31","article-title":"Secondary Resistance to dopamine agonist after thirteen months of successful treatment in a 42 years old man","volume":"108","author":"Laboy-Ortiz","year":"2016","journal-title":"Bol. Asoc. Med. P. R."},{"issue":"10","key":"10.1016\/j.canlet.2019.05.043_bib42","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1210\/jc.2017-00627","article-title":"Pituitary tumor suppression by combination of cabergoline and chloroquine","volume":"102","author":"Lin","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.canlet.2019.05.043_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12022-009-9057-3","article-title":"Invasive giant prolactinoma with loss of therapeutic response to cabergoline: expression of angiogenic markers","volume":"20","author":"Mallea-Gil","year":"2009","journal-title":"Endocr. Pathol."},{"issue":"1","key":"10.1016\/j.canlet.2019.05.043_bib44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2265.2006.02686.x","article-title":"Unusual late development of dopamine agonist resistance in two women with hyperprolactinaemia associated with transition from micro to macroadenoma","volume":"66","author":"McCall","year":"2007","journal-title":"Clin. Endocrinol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519303441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519303441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T07:30:22Z","timestamp":1721374222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383519303441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":44,"alternative-id":["S0304383519303441"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2019.05.043","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DEPTOR inhibits cell proliferation and confers sensitivity to dopamine agonist in pituitary adenoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2019.05.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}